MedPath

Effect of androgen deprivation therapy on bladder cancer recurrence.

Not Applicable
Recruiting
Conditions
Bladder cancer and prostate cancer
Registration Number
JPRN-UMIN000012926
Lead Sponsor
Yokohama Cancer of Prostate Group
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Male
Target Recruitment
200
Inclusion Criteria

Not provided

Exclusion Criteria

Bladder cancer except for urothelial cancer.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Recurrence free survival Cumulative recurrence
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath